Reuters logo
2 months ago
BRIEF-Moleculin announces intent to expand annamycin planned clinical trial
June 15, 2017 / 11:18 AM / 2 months ago

BRIEF-Moleculin announces intent to expand annamycin planned clinical trial

June 15 (Reuters) - Moleculin Biotech Inc:

* Moleculin announces intent to expand annamycin planned clinical trial to include sites in Poland

* Moleculin Biotech - asked contract research organization to include clinical sites in poland for planned phase I/II clinical trial of annamycin Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below